Trillium Therapeutics Inc. is a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer. We employ biologic and small molecule-based approaches that enhance the ability of the patient’s own immune system to detect and destroy cancer cells.

Read More

Press Releases

View All News

Featured Presentation

Last updated on December 7, 2020